Dynamic alteration of low-density lipoprotein receptor after exposure to transforming growth factor-β2 in human Tenon's capsule fibroblasts

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 6, 2009, Pages 499-506

  Shao, Tingting ^a   Gao, Qianying ^a   Jiang, Ruzhang ^a   Duan, Yongheng ^a   Sun, Xuerong ^a   Ge, Jian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYANINE DYE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA2;

ADULT; ARTICLE; CATARACT EXTRACTION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; FLUORESCENCE ANALYSIS; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TENON CAPSULE FIBROBLAST; WESTERN BLOTTING;

BLOTTING, WESTERN; CARBOCYANINES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE; FEMALE; FIBROBLASTS; GENE EXPRESSION; HUMANS; LIPOPROTEINS, LDL; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PROTEIN BINDING; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA2;

EID: 77149173736     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0042     Document Type: Article

References (31)

1. Khaw, P.T., Chang, L., Wong, T.T., et al. Modulation of wound healing after glaucoma surgery. Curr. Opin. Ophthalmol. 12:143-148, 2001.
2. Chang, L., Crowston, J.G., Cordeiro, M.F., et al. The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv. Ophthalmol. 45:49-68, 2000.
3. Mearza, A.A., and Aslanides, I.M. Uses and complications of mitomycin C in ophthalmology. Expert Opin Drug Saf. 6:27-32, 2007.
4. Wong, T.T., Mead, A.L., and Khaw, P.T. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. Invest. Ophthalmol. Vis. Sci. 46:2018-2022, 2005.
5. Akyol, N., and Akpolat, N. Effects of intraoperative oxidated regenerated cellulose on wound healing reaction after glaucoma filtration surgery: A comparative study with Interceed and Surgicel. Indian J. Ophthalmol. 56:109-114, 2008.
6. Kitano, A., Saika, S., Yamanaka, O., et al. Genipin suppresses subconjunctival fibroblast migration, proliferation and myofi-broblast transdifferentiation. Ophthalmic Res. 38:355-360, 2006.
7. Cordeiro, M.F., Bhattacharya, S.S., Schultz, G.S., et al. TGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration. Invest Ophthalmol. Vis. Sci. 41:756-763, 2000.
8. Grisanti, S., Szurman, P., Warga, M., et al. Decorin modulates wound healing in experimental glaucoma filtration surgery: a pilot study. Invest.Ophthalmol. Vis. Sci. 46:191-196, 2005.
9. Vidro, E.K., Gee, S., Unda, R., et al. Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release. Curr. Eye Res. 33:984-993, 2008.
10. Joshi, A.B., Parrish, R.K., II, and Feuer, W.F. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J. Glaucoma. 14(2):172-174, 2005.
11. DeBry, P.W., Perkins, T.W., Heatley, G., et al. Incidence of lateonset bleb-related complications following trabeculectomy with mitomycin. Arch. Ophthalmol. 120:297-300, 2002.
12. Jin, S., and Ye, K. Nanoparticle-mediated drug delivery and gene therapy. Biotechnol. Prog. 23:32-41, 2007.
13. Chen, H.Y., Ge, J., Guo, Y., et al. The inhibition effect of photodynamic on human Tenon capsule fibroblast cells. Zhonghua Yan Ke Za Zhi. 39:160-162, 2003.
14. Jordan, J.F., Diestelhorst, M., Grisanti, S., et al. Photodynamic modulation of wound healing in glaucoma filtration surgery. Br. J. Ophthalmol. 87:870-875, 2003.
15. Li, H., Gray, B.D., Corbin, I., et al. MR and fluorescent imaging of low-density lipoprotein receptors. Acad. Radiol. 11:1251-1259, 2004.
16. Nikanjam, M., Blakely, E.A., Bjornstad, K.A., et al. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme. Int. J. Pharm. 328:86-94, 2007. (Pubitemid 44827556)
17. Ozcan, A.A., Ozdemir, N., and Canataroglu, A. The aqueous levels of TGF-beta2 in patients with glaucoma. Int. Ophthalmol. 25:19-22, 2004.
18. Zhang, Y., Gao, Q., Duan, S., et al. Upregulation of Copine1 in trabecular meshwork cells of POAG patients: a membrane proteomics approach. Mol. Vis. 14:1028-1036, 2008.
19. Weisgraber, K.H., and Rall, S.C., Jr. Human apolipoprotein B-100 heparin-binding sites. J. Biol. Chem. 262:11097-11103, 1987.
20. Pitas, R.E., Innerarity, T.L., Weinstein, J.N., et al. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis. 1:177-185, 1981.
21. Cordeiro, M.F., Chang, L., Lim, K.S., et al. Modulating conjunctival wound healing. Eye. 14(Pt 3B):536-547, 2000.
22. Meyer-Ter-Vehn, T., Grehn, F., and Schlunck, G. Localization of TGF-beta type II receptor and ED-A fi bronectin in normal conjunctiva and failed filtering blebs. Mol Vis. 14:136-141, 2008.
23. Kottler, U.B., Junemann, A.G., Aigner, T., et al. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma. Exp. Eye Res. 80:121-134, 2005.
24. Narine, K., De Wever, O., Van Valckenborgh, D., et al. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering. Tissue Eng. 12:2707-2716, 2006.
25. Corbin, I.R., Li, H., Chen, J., et al. Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents. Neoplasia. 8:488-498, 2006.
26. Dozzo, P., Koo, M.S., Berger, S., et al. Synthesis, characterization, and plasma lipoprotein association of a nucleus-targeted boronated porphyrin. J. Med. Chem. 48:357-359, 2005.
27. Hammel, M., Laggner, P., and Prassl, R. Structural characterisation of nucleoside loaded low density lipoprotein as a main criterion for the applicability as drug delivery system. Chem. Phys. Lipids. 123:193-207, 2003.
28. Wickline, S.A., Neubauer, A.M., Winter, P.M., et al. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. J. Magn. Reson. Imaging. 25:667-680, 2007.
29. Anand, N., Arora, S., and Clowes, M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br. J. Ophthalmol. 90:175-180, 2006.
30. Sherwood, M.B. A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). Trans. Am. Ophthalmol. Soc. 104:478-492, 2006.
31. Abraham, L.M., Selva, D., Casson, R., et al. Mitomycin: clinical applications in ophthalmic practice. Drugs. 66:321-340, 2006.